Outcomes of HIDAC 18 g Versus IDAC 9 g in Consolidation Therapy of Acute Myeloid Leukemia: A Retrospective Study
ConclusionFor AML consolidation IDAC had lesser toxicity when compared with HIDAC though comparable efficacy needs to be confirmed with longer follow up and with prospective studies.
Source: Indian Journal of Hematology and Blood Transfusion - Category: Hematology Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Blood Transusion | Hematology | India Health | Leukemia | Study | Toxicology